SCHEMBL6000126

SCHEMBL6000126

O=C(O)C1(c2ccccc2)CCN(Cc2nc(-c3ccc(NCCC4CCC(c5ccc(Cl)cc5)CC4)cc3)cs2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 9/20 0.43
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
P2RX7 Q99572 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
HSD11B1 P28845 1/20 0.36
IDO1 P14902 1/20 0.36
FAAH O00519 1/20 0.36
EPHX2 P34913 1/20 0.36
HTT P42858 1/20 0.36
NAMPT P43490 1/20 0.35
LTA4H P09960 1/20 0.35
TRPV1 Q8NER1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000114 0.84 NPC1 (0.37) CHRM4NPC1CYP1A2MAPTCYP2C9
SCHEMBL6000118 0.84 NPC1 (0.37) CHRM4NPC1CYP1A2MAPTCYP2C9
SCHEMBL6000920 0.84 MEN1 (0.39) NPC1RAB9AHTTNAMPTLTA4H
SCHEMBL6000199 0.78 NAMPT (0.38) CHRM4NPC1CYP1A2MAPTCYP2C9
SCHEMBL6000685 0.75 LTA4H (0.37) NPC1MAPTRAB9AHTTNAMPT
SCHEMBL6000690 0.75 LTA4H (0.37) NPC1MAPTRAB9AHTTNAMPT
SCHEMBL6000915 0.74 CTSL (0.38) RAB9AHTTLTA4H
SCHEMBL6000503 0.69 GCGR (0.40) NPC1MAPTRAB9ANAMPT
SCHEMBL6001096 0.69 CTSL (0.39) NPC1RAB9AHTTNAMPT
SCHEMBL6000650 0.68 MAPK1 (0.40) NPC1RAB9AHTTNAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 CHRM4 1673/4885NPC1 955/4885CYP1A2 200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.